Key Points
- Correct patient and specimen identification is the first pathology safety step.
- Orientation should answer a clinical margin or anatomic question and be communicated before grossing.
- Most routine tissue requires prompt adequate formalin fixation.
- Cold ischemia and fixation time can affect predictive biomarker validity.
- Lymphoma, microbiology, renal, muscle, nerve, and cytogenetic specimens often need special handling.
- Frozen section should be reserved for questions that change intraoperative management.
- Small specimens should be triaged to preserve tissue for required ancillary studies.
- Preanalytic limitations should be documented rather than hidden.
Algorithm
- Confirm identifiers, anatomic site, and specimen designation at collection.
- Decide whether orientation or specimen radiography is needed before fixation.
- Identify any need for culture, flow cytometry, cytogenetics, molecular testing, frozen section, immunofluorescence, or electron microscopy.
- Place routine tissue promptly in sufficient neutral buffered formalin.
- Route special specimens fresh or in the required medium according to pathology protocol.
- Communicate urgent intraoperative questions directly with the pathologist.
- Document cold ischemia, fixation, orientation markers, and any handling problem.
- Reconcile pathology findings with the operative question and pursue clarification when margins or site are ambiguous.
Clinical Synopsis & Reasoning
The pathology report can only be as reliable as the specimen that reaches the laboratory. Preanalytic errors include wrong-patient labeling, ambiguous orientation, delayed fixation, insufficient formalin, crush or cautery artifact, drying, and placing tissue needed for microbiology or flow cytometry into formalin. These errors can make margins uninterpretable, compromise immunohistochemistry or molecular testing, and occasionally require repeat surgery. Every specimen should therefore be labeled at the bedside or procedure field with at least the identifiers required by institutional policy, anatomic site, and specimen designation.
Orientation is most valuable when it answers a surgical question. Sutures, clips, inks, diagrams, and clearly named margins can distinguish superior from inferior, medial from lateral, or true margin from nonmargin surface. Orientation should be communicated before the specimen is distorted by opening or sectioning. For complex resections, surgeon and pathologist discussion can prevent a technically correct but clinically useless margin report. Specimen radiography can confirm localization clips, calcifications, wires, seeds, or target lesions in breast and other image-guided resections.
Routine tissue is usually fixed in 10% neutral buffered formalin at an adequate volume relative to tissue. Large specimens should be opened or grossed promptly so fixative reaches deep tissue. Fixation time matters for predictive biomarkers, especially breast ER, PR, and HER2. Do not place tissue in saline and leave it unattended for hours. Cold ischemia should be minimized and documented when biomarker validity depends on it.
Treatment Strategy & Disposition
Exceptions to formalin are clinically important. Tissue for lymphoma evaluation should often be submitted fresh in appropriate medium because flow cytometry, cytogenetics, and molecular studies may be required. A portion of suspected infection tissue should go sterile to microbiology rather than formalin. Kidney biopsy cores are divided among formalin, immunofluorescence medium, and electron microscopy fixative. Muscle and nerve biopsies require specialized handling because routine formalin alone can destroy diagnostic enzyme, ultrastructural, or immunologic information. Products of conception may need fresh tissue for cytogenetic or molecular analysis when requested.
Frozen section requires fresh tissue and a focused intraoperative question. It is most useful when the answer will change the current operation, such as margin status, tissue identification, or selected metastatic disease. Freezing introduces artifact and consumes tissue, so it should not be ordered merely for curiosity or when permanent sections will answer the question without affecting immediate management. Small biopsies intended for molecular testing should be conserved.
Pathology laboratories should have accession checks, gross-description standards, fixation documentation, and escalation procedures for mislabeled or compromised specimens. When a specimen is unintentionally placed in the wrong medium, contact pathology immediately rather than attempting an improvised rescue. A transparent limitation in the final report is safer than silently reporting a compromised result.
Epidemiology / Risk Factors
- Preanalytic pathology errors are less common than diagnostic interpretation errors but can be equally consequential.
- Increasing molecular testing makes tissue stewardship more important than in the past.
- Small biopsy and neoadjuvant-treatment specimens frequently require coordinated ancillary testing.
- Standardized CAP protocols improve completeness and reproducibility of cancer reporting.
Investigations
| Test | Role / Rationale | Typical Findings | Notes |
|---|---|---|---|
| Specimen identifiers | Prevents wrong-patient or wrong-site error | Complete, concordant labeling | Resolve discrepancies before processing |
| Gross examination | Documents size, orientation, lesions, margins, and sampling | Structured description | Guides block selection |
| Specimen radiograph | Confirms target lesion or localization device | Clip, calcification, seed, wire, lesion | Common in image-guided breast specimens |
| Ancillary test planning | Preserves tissue for flow, molecular, culture, EM, or IF | Appropriate material available | Plan before exhaustive sectioning |
| Fixation monitoring | Assures valid morphology and biomarkers | Recorded cold ischemia and fixation where needed | Especially important in breast predictive testing |
Common Exceptions to Formalin
| Specimen | Handling |
|---|---|
| Lymph node for suspected lymphoma | Send fresh portion for flow cytometry and ancillary studies; reserve formalin-fixed tissue for histology |
| Tissue for culture | Send sterile and unfixed to microbiology |
| Renal biopsy | Divide for light microscopy, immunofluorescence, and electron microscopy |
| Muscle biopsy | Coordinate fresh or frozen specialized handling before collection |
| Products of conception for genetics | Send designated fresh tissue according to cytogenetics protocol |
| Routine resection | Promptly place in adequate neutral buffered formalin after any needed orientation or radiography |
Pharmacology
| Medication | Mechanism | Onset | Role in Therapy | Limitations |
|---|---|---|---|---|
| 10% neutral buffered formalin | Cross-links proteins and preserves morphology | Hours | Routine surgical pathology fixation | Precludes culture and many fresh-tissue studies |
| Michel or other IF transport medium | Preserves immune reactants | Immediate | Selected renal or dermatologic immunofluorescence | Not a routine histology fixative |
| Glutaraldehyde | Excellent ultrastructural preservation | Immediate | Electron microscopy portions | Poor for many routine immunostains |
| Saline or tissue culture medium | Keeps tissue unfixed temporarily | Immediate | Selected flow cytometry or cytogenetics | Requires prompt processing; do not leave at room temperature indefinitely |
Prognosis / Complications
- Well-handled specimens support accurate diagnosis, staging, margins, and predictive biomarker testing.
- Poor handling can create indeterminate results, repeat procedures, or incorrect treatment decisions.
- Most handling problems are preventable through standardized collection and communication.
- When compromise occurs, prognosis depends on whether enough valid tissue remains to answer the clinical question.
Patient Education / Counseling
- Patients usually do not need to manage specimen handling themselves, but clinicians should explain if additional tissue or repeat biopsy becomes necessary because the original sample was insufficient.
- Surgeons should tell the pathology team about orientation markers and any specific margin concern.
- When genetic or molecular studies are anticipated, discuss tissue needs before the procedure when possible.
- Clinicians should review pathology limitations, not just the final diagnostic line.
- If a result is unexpected, verify specimen site and radiologic or operative concordance before acting.
Notes
Specimen handling is part of diagnosis, not logistics after the 'real' procedure. The most useful question before placing tissue in a container is: what tests might be needed that formalin would prevent?
Institutions should maintain readily accessible collection instructions because special handling cannot be reconstructed after fixation. When uncertain, a brief call to pathology before collection is usually safer than attempting to correct the specimen later.
References
- College of American Pathologists: Current Cancer Protocols and Specimen Guidance — Link
- College of American Pathologists: Current CAP Guidelines — Link
Practice the decision pattern next.
Most students do not plateau because they refuse to study. They plateau because their review does not show the exact reasoning error behind repeated misses. MDSteps turns topic review into targeted blocks, explanations, flashcards, and readiness signals.
- Full access to 1,100+ medical reference articles linked directly to relevant QBank concepts
- 16,000+ USMLE-style questions across Step 1, Step 2 CK, and Step 3
- Depth-on-Demand™ explanations that isolate the pivot clue, distractor trap, and decision point
- CCS cases with live vitals, order timing, reassessment, and after-action feedback